NEW YORK (GenomeWeb News) – A White House advisory panel today recommended that any researchers, clinicians, and direct-to-consumer firms that generate genomic, imaging, or other types of biomedical data should plan to encounter incidental findings and should communicate with patients, study participants, and consumers about how these findings will be handled.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.